We are live on ! Find out more
CRKN

Crown Electrokinetics Corp. Common Stock

Delisted

CRKN was delisted on the 4th of March, 2025.

1 hedge funds and large institutions have $4.56M invested in Crown Electrokinetics Corp. Common Stock in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

44% less capital invested

Capital invested by funds: $8.13M → $4.56M (-$3.57M)

Holders
1
Holders Change
+1
Holders Change %
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

CRKN Hedge Fund Activity: Q1 2022 in Review

1 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Crown Electrokinetics Corp. Common Stock (CRKN) for Q1 2022, worth a combined $4.56M — down 44% from $8.13M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new CRKN positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $3.1M. The largest seller was Hohimer Wealth Management, cutting an estimated $284K.

  • 1 institutional investor held Crown Electrokinetics Corp. Common Stock (CRKN) as of Q1 2022, up from 0 in Q4 2021.
  • Funds reported $4.56M of Crown Electrokinetics Corp. Common Stock stock for Q1 2022, down 44% quarter-over-quarter.
  • 1 fund opened new Crown Electrokinetics Corp. Common Stock positions in Q1 2022 and 0 closed out, a net change of +1 holder.
  • The largest Crown Electrokinetics Corp. Common Stock buyer in Q1 2022 was Vanguard Group, an estimated $3.1M added.
  • The largest Crown Electrokinetics Corp. Common Stock seller in Q1 2022 was Hohimer Wealth Management, an estimated $284K sold.

Based on aggregated 13F filings for Q1 2022.